Independent Advisor Alliance

Position in AVXL — Anavex Life Sciences Corp.

CIK 1696899 CHARLOTTE, NC

Position in AVXL

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$93,867

-$84,402 QoQ

Shares Held

30,576

-38.9% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Independent Advisor Alliance holds $6,039,391 across 21 Biotechnology names. AVXL ranks #13 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,267	$1,458,846
2	ARQT	Arcutis Biotherapeutics, Inc.	31,597	$744,424
3	REGN	Regeneron Pharmaceuticals, Inc.	725	$560,163
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,602	$530,052
5	ABSI	Absci Corp	153,855	$461,565
6	INCY	Incyte Corp	4,794	$451,211
7	CRSP	CRISPR Therapeutics AG	7,907	$376,135
8	GPCR	Structure Therapeutics Inc.	7,444	$358,800

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$93,867	30,576	-38.9%	Shares	Sole	2026-05-12
2025-12-31	$178,269	50,076	+4.8%	Shares	Sole	2026-02-04
2025-09-30	$425,410	47,799	+5.7%	Shares	Sole	2025-11-04
2025-06-30	$416,798	45,206	-2.9%	Shares	Sole	2025-08-11
2025-03-31	$399,432	46,554	0.0%	Shares	Sole	2025-05-12
2024-12-31	$499,989	46,554	-0.6%	Shares	Sole	2025-02-07
2024-09-30	$266,090	46,847	-1.2%	Shares	Sole	2024-11-13
2024-06-30	$200,044	47,404	0.0%	Shares	Sole	2024-08-12
2024-03-31	$241,286	47,404	-0.5%	Shares	Sole	2024-05-08
2023-12-31	$443,565	47,644	+10.4%	Shares	Sole	2024-02-08
2023-09-30	$282,593	43,144	+54.6%	Shares	Sole	2023-10-24
2023-06-30	$226,835	27,901	-2.2%	Shares	Sole	2023-07-28
2023-03-31	$244,502	28,530	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.